Neuronetics, Inc. is a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. Based in Malvern, PA, they are the leader in the development of TMS Therapy (transcranial magnetic stimulation), a non-invasive form of neuromodulation.
Current Team (12)Update
Chief Medical Officer
VP Product Development and Operations
VP of Health Policy and Government Relations
VP New Business Development
VP Regulatory Affairs and Quality Assurance
Funding Rounds (4) - $60.3MUpdate
Board Members and Advisors (5)Update
Three Arch Partners was formed in 1993 to provide young companies with access to relevant...
InterWest invests an average of about $7 - 15 million over the span of their involvement with...
At ONSET, they believe in collaboration. Over 20 years of experience tells them that companies...
Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads...
Pfizer Venture Investments (PVI) serves as the venture capital arm of Pfizer, supporting a...
Polaris Partners is a venture company investing in digital media, life sciences, and enterprise...
Health-Care Focused VC Firm
Venture Capital Firm
31 General Warren Blvd.
Malvern, PA 19355